Capricor Therapeutics, Inc. (CAPR)
NASDAQ·Healthcare·Biotechnology
$8.65
-3.78%
Mkt Cap $516.57M
Analyst Ratings
Buy
4
Hold
4
Sell
0
Price Target (22 analysts)
$12.70
Range $3.50 – $25.00
Implied Upside
+46.8%
Consensus $12.70 vs current $8.65
NASDAQ·Healthcare·Biotechnology
$8.65
-3.78%
Mkt Cap $516.57M
Buy
4
Hold
4
Sell
0
Price Target (22 analysts)
$12.70
Range $3.50 – $25.00
+46.8%
Consensus $12.70 vs current $8.65